Last reviewed · How we verify

NCT03281525: SQ_Heart

Sleep Quality Underwent Heart Transplant, an Observational Study

Completed Last updated 4 December 2020
What this trial tests

trial in Ventricular Dysfunction in 176 participants. Completed in 30 September 2017.

Timeline
11 April 2017
Primary endpoint
30 September 2017
30 September 2017

Quick facts

Lead sponsorUniversity of Padova
StatusCompleted
Study typeOBSERVATIONAL
Enrollment176
Start date11 April 2017
Primary completion30 September 2017
Estimated completion30 September 2017
Sites1 location across Italy

Conditions studied

Sponsor

University of Padova

Who can join

Adults 18 to 90, any sex, with Ventricular Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The SQ\_Heart has been designed as an observational study that evaluates the difference in sleep quality between 11 patients with VAD (Ventricular Assisted Device) and 98 Cardiotransplant patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Ventricular Dysfunction

Currently open trials in the same condition.

Other University of Padova trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03281525.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing